pre 084 has been researched along with chelerythrine in 1 studies
Studies (pre 084) | Trials (pre 084) | Recent Studies (post-2010) (pre 084) | Studies (chelerythrine) | Trials (chelerythrine) | Recent Studies (post-2010) (chelerythrine) |
---|---|---|---|---|---|
116 | 0 | 73 | 1,115 | 1 | 269 |
Protein | Taxonomy | pre 084 (IC50) | chelerythrine (IC50) |
---|---|---|---|
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 1.2 | |
Cholinesterase | Homo sapiens (human) | 8.58 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.55 | |
Acetylcholinesterase | Homo sapiens (human) | 1.45 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.566 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casas, C; Guzmán-Lenis, MS; Navarro, X | 1 |
1 other study(ies) available for pre 084 and chelerythrine
Article | Year |
---|---|
Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons.
Topics: Animals; Benzophenanthridines; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Glutamic Acid; In Vitro Techniques; Morpholines; Motor Neurons; Neurites; Neurons; Neuroprotective Agents; Neurotoxins; Piperazines; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, sigma; Signal Transduction; Spinal Cord | 2009 |